Waking up CML leukemia stem cells for the kill
Blood
.
2022 Feb 3;139(5):647-648.
doi: 10.1182/blood.2021014629.
Authors
Kaosheng Lv
1
2
,
Wei Tong
1
2
Affiliations
1
Children's Hospital of Philadelphia.
2
Perelman School of Medicine at the University of Pennsylvania.
PMID:
35113154
PMCID:
PMC8814681
DOI:
10.1182/blood.2021014629
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Leukemia, Myeloid, Acute*
Stem Cells
Substances
Imatinib Mesylate
Grants and funding
R01 CA271523/CA/NCI NIH HHS/United States
R01 DK127738/DK/NIDDK NIH HHS/United States
R01 HL095675/HL/NHLBI NIH HHS/United States
R01 HL133828/HL/NHLBI NIH HHS/United States